1,721,589 research outputs found
Da cheng qi xin lun 大 乘 起 信論 par AŚvaghoṣa 馬 鳴.
No full textMahāyana-śraddhotpāda-śāstra, cf. Da cheng qi xinlun.Da cheng qi xin lun 大 乘 起 信 論Mahāyāna-śraddhotpāda-śāstraNumérisation effectuée à partir d'un document original.Fin de la préface et texte complet en 1 j.T . 1666, vol. 32, pp. 575 a 22.583 b. Petite écr. call. Encre tantôt pâle, tantôt foncée. Raresadditions et corrections. 34 à 39 col. par f., 23 à 28 car. par col. Marges maltracées, sup. 1,9 à 2,8 cm, inf. 2,5 à 3,2 cm. Réglure
Da cheng qi xin lun lüe shu 大 乘 起 信 論 略 述 parTan kuang 曇 曠.
No full textDa chengqi xin lun lüe shu 大 乘 起 信 論 畧 述Da cheng qi xin lun lüe shu shu大 乘 起 信 論 畧 述 疏, cf. Da cheng qi xin lun lüe shu.Numérisation effectuée à partir d'un document original.J. xia complet. Éd.T . 2813, vol. 85, pp. 1105a-1121 c. Écr. cursive, encre plus ou moins foncée. 2 ou 3 car. cursifs ajoutés à l'encre pâle sur la plupart des ff., le plus souvent sur les car. du texte, quelquefois près du raccord des ff. Très rares additions. 921 col. entout. 27 à 35 col. par f., 22 à 26 car. par col. Marges non tracées, sup. 1 à1,2 cm, inf. 0,8 à 1,5 cm
Da-Cheng-Qi Decoction Combined with Conventional Treatment for Treating Postsurgical Gastrointestinal Dysfunction
Get PDFAim. To assess the current clinical evidence of the effectiveness of Da-Cheng-Qi Decoction (DCQD) for the treatment of Postoperative gastrointestinal dysfunction (PGD).Methods. Randomized controlled trails (RCTs) of Da-Cheng-Qi Decoction (DCQD) to PGD were searched from available major electronic databases to September 2016. The intervention must be a modified DCQD or DCQD integrated to Western Medicine (WM) compared with WM or placebo or blank. The main outcome index was clinical effectiveness and improvement of major symptoms. Data extraction, data analysis, and methodological quality assessment are conducted according to the Cochrane Handbook for Systematic Review of Interventions, version 5.0.2. RevMan 5.3 software was applied to our data analyses.Results. Seven RCTs involving 494 participants were recruited and identified. The methodological quality of all trials were assessed and generally of low-level. Those studies were published between 2004 and 2013. All 7 studies which used herbals (modified DCQD) integrate WM in test group compared with WM as the intervention and only one study (Sunyouxu 2013) integrates placebo to Western Medicine as the control group intervention. The treatment course was 1 week to 2 weeks. Evaluation of intervention effectiveness consists of the clinical effective rate indicator and the PGD symptoms indicator including time of borborygmus, time of gastrointestinal exhaust, and time of defecate. The clinical effectiveness results are beneficial to the test group.Conclusion. DCQD could improve PGD symptoms and promotion clinical effectiveness.</jats:p
Da cheng qi xin lun 大 乘 起 信 論 parAŚvaghoṣa 馬 鳴.
No full textMahāyana-śraddhotpāda-śāstra, cf. Da cheng qi xin lun.Dacheng qi xin lun 大 乘 起 信 論Mahāyāna-śraddhotpāda-śāstraNumérisation effectuée à partir d'un document original.Complet en 1 j., avec préface complète de Zhi kai 智 愷 de Yangzhou 楊 州. T . 1666, vol. 32, pp.575 a-583 b. Écr. call., traits empâtés. Les 3 premières sections dulun (ff. 2-24) sont ponctuées en rouge. Quelquesadditions, corrections et ratures en rouge et en noir (ff. 1 à 16). F. 8 :texte récrit sur une réparation d'origine. 23 ou 24 col. par f., 16 à 18 car.par col. Marges sup. 2,1 à 3,4 cm, inf. 2 à 3,8 cm. Réglure
Solid-phase microextraction-gas chromatography-mass spectrometric analysis of volatile compounds in a compounded Chinese medicinal prescription, Xiao-Cheng-Qi-Tang
No full textIn this paper, a headspace solid-phase microextraction (HS-SPME) coupled to gas chromatography-mass spectrometry (GC-MS) was applied for the analysis of volatile compounds in a famous compounded Chinese medicinal prescription, Xiao-Cheng-Qi-Tang. Some parameters affecting the extraction efficiency such as stirring, extraction temperature, fiber exposure time and desorption time were optimized. The best results were obtained using a 100 μm PDMS fiber during headspace extraction at 90°C with stirring at 1000 rpm for 20 min. Twenty-seven compounds were identified in Xiao-Cheng-Qi-Tang including some main compounds such as D-limonene and linalool. Inter- and intra-day relative standard deviations (R.S.Ds.) were less than 15.6%, showing that the method had a good reproducibility. The result might provide some foundation for building the convincing theory on the pharmacological activity of this prescription. © 2004 Elsevier B.V. All rights reserved.link_to_subscribed_fulltex
Pharmacokinetic and Pharmacodynamic Studies of Four Major Phytochemical Components of Da-Cheng-Qi Decoction to Treat Acute Pancreatitis
No full textThe medicinal herb formulation Da-Cheng-Qi decoction (DCQD) has been shown to ameliorate the severity of acute pancreatitis by regulating an apoptosis–necrosis switch in cells. The active components responsible for this effect and their detailed mechanism of action remain unclear. Here we determine the pharmacokinetic characteristics of the four most abundant compounds in DCQD using a rat model of severe acute pancreatitis. Acute pancreatitis-like symptoms were first induced in rats and then they were given DCQD orally. Rhein was found in rat serum at much higher levels than magnolol, hesperidin, or naringin, even though it was the least abundant of the four compounds in the DCQD. We also examined pharmacodynamics in AR42J cells stimulated with 10−8 M cerulein as a cellular model of acute pancreatitis. After pretreating AR42J cells with individual compounds and then exposing them to cerulein, we determined cell viability, levels of apoptosis and necrosis, and numbers of cells positive for reactive oxygen species (ROS). Pretreatment with any of the four DCQD compounds increased cell viability and the apoptosis index, while also reducing necrosis and ROS generation. The compounds showed maximal effect in AR42J cells around the same time that they showed maximum serum concentration in rats. Although all four components appear to play a role in an apoptosis–necrosis cellular switch in vitro, rhein may be the most bioactive DCQD ingredient. Keywords:: Da-Cheng-Qi decoction, pharmacokinetic/pharmacodynamics, acute pancreatitis, cytoprotectio
Da-Cheng-Qi decoction, a traditional Chinese herbal formula, for intestinal obstruction: Systematic review and meta-analysis
Get PDFBackground: This study was aimed at determining the effects and safety of Da-Cheng-Qi decoction (DCQD) or DCQD combined with conservative therapy in patients with intestinal obstruction.Materials and Methods: PubMed, EMBASE, Cochrane Controlled Trials Register, and several other databases were searched. Randomised controlled trials (RCTs) of DCQD or DCQD plus conservative therapy in patients with intestinal obstruction were eligible. Therapeutic effect was estimated by the improvement of clinical manifestations and diagnostic imaging; dichotomous/ordinal data assessment of overall response to therapy, adverse effects; or continuous variable were identified, including time to first bowel movement, time to first flatus, length of hospital stay.Results: Sixty eligible RCTs including 6,095 patients were identified. Response rate: (1) DCQD versus conservative therapy (6 RCTs, 361 patients, RR of respond =1.13; 95% CI 0.97 to 1.31). (2) DCQD plus conservative therapy versus conservative therapy (48 RCTs, 4,916 patients,RR of respond =1.25 which favoured DCQD plus conservative therapy; 95% CI 1.20 to 1.30). Treatment effect remained similar when RCTs at high risk of bias were excluded. Time to first flatus postoperatively: (1) DCQD versus conservative therapy (2 RCTs, 240 patients, SMD=-3.65; 95% CI -8.17 to 0.87). (2) DCQD plus conservative therapy versus conservative therapy (11 RCTs, 1,040 patients, SMD=-2.09 which favoured DCQD plus conservative therapy; 95% CI -3.04 to -1.15).Conclusion: DCQD combined with conservative therapy may increase the success rate of conservative therapy for intestinal obstruction significantly and can shorten the duration of postoperative ileus in patients undergoing abdominal surgery compared with conservative therapy alone.Key words: Da-Cheng-Qi-Tang; Intestinal Obstruction; Ileus; Intestinal Pseudo-Obstruction; Meta-Analysis.Introductio
Design and Analysis of Three-Stage Amplifier for Driving pF-to-nF Capacitive Load Based on Local Q-Factor Control and Cascode Miller Compensation Techniques
No full textThis paper presents a new frequency compensation approach for three-stage amplifiers driving a pF-to-nF capacitive load. Thanks to the cascode Miller compensation, the non-dominant complex pole frequency is extended effectively, and the physical size of the compensation capacitors is also reduced. A local Q-factor control (LQC) loop is introduced to alter the Q-factor adaptively when loading capacitance CL varies significantly. This LQC loop decides how much damping current should be injected into the corresponding parasitic node to control the Q-factor of the complex-pole pair, which affects the frequency peak at the gain plot and the settling time of the proposed amplifier in the closed-loop step response. Additionally, a left-half-plane (LHP) zero is created to increase the phase margin and a feed-forward transconductance stage is paralleled to improve the slew rate (SR). Simulated in 0.13-µm CMOS technology, the amplifier is verified to handle a 4-pF-to-1.5-nF (375× drivability) capacitive load with at least 0.88-MHz gain-bandwidth (GBW) product and 42.3° phase margin (PM), while consuming 24.0-µW quiescent power at 1.0-V nominal supply voltage
The Anti-Hepatitis Effect by Tao-He-Cheng-Qi-Tang on Acetaminophen (APAP) Induced Rats
No full text[[abstract]]"Tao-He-Cheng-Qi-Tang (THCQT) for medical purposes
has been known for centuries. It has been recognized to
as a means to treat diabetes mellitus, amenorrhea, chronic
hepatitis, and chronic pyelonephritis. In order to test
for THCQT’s ability to scavenge free radicals, we examined the ability of THCQT to react with hydroxyl
radical to investigate the effect of THCQT on acetaminophen (APAP)-induced hepatitis. Male Wistar rats
were administered with 0.3 or 0.5 g/kg of THCQT, and
silymarin (25 mg/kg) as the positive control group. All
testing substances were orally administered 1 h before
the intraperitoneal injection of APAP (500 mg/kg). After
24 h of APAP injection, the rats were sacrificed to
observe their liver histopathology, and evaluated for
their glutamate oxalate transaminase (GOT), glutamate
pyruvate transaminase (GPT), and lipid peroxidation
(LPO) level. THCQT significantly inhibited LPO level
induced by Fe3+/ascorbic acid in vitro. THCQT protected
the liver from APAP-induced injuries by preventing the
increase of liver function markers, GOT and GPT. THCQT
even showed more significantly effects than the silymarin.
Although THCQT did not significantly change the increase
of hepatic LPO induced by APAP, THCQT did increase
hepatic glutathione (GSH) more significantly than the
APAP group and the silymarin group. We concluded
that the antioxidant abilities and anti-hepatitis effect of
THCQT may be potentially useful in counteracting free
radical-mediated diseases.
- …
